Effect of Dashmool Visva decoction and punarnava Mandoor in Kaphaj Pandu (Anaemia)

Phase 4

Completed

• Conditions: Iron deficiency anemia, unspecified. Ayurveda Condition: PANDUROGAH,

• Registration Number: CTRI/2023/02/049593
• Lead Sponsor: Ch Brham Prakash Ayurved Charak Sansthan

Brief Summary

Pandu is a rasa pradoshaj vikar, it is due to excessive exacerbations of three doshasespecially pitta afflicts dhatus as a result complexion, strength, unctuousness and other property also get too much diminished due to morbidity of dosha and dushyaand then blood, fat and ojas get exceedingly reduced leading to development of Pandu roga. Pandu is a symptom as well as a disease characterized by pallor discolouration.

Anaemia is a condition in which the number of red blood cells or the Haemoglobin concentration within them is lower than normal. Haemoglobin is needed to carry oxygen and if you have too few or abnormal red blood cells, or not enough Haemoglobin, there will be a decreased capacity of the blood to carry oxygen to the body’s tissues. This results in symptoms such as Fatigue, Weakness, Dizziness and Shortness of breath, among others. The signs include loss of normal colour in the skin and also in the lips, tongue, nail beds and the blood vessels in the sclera part of the eye. Without treatment, Anaemia can worsen and become underlying causes of chronic ill health, such as impaired foetal development during pregnancy, delayed cognitive development and increased risk of infection in young children and reduced physical capacity in all people.



This study is to compare the efficacy of Dashmool Visva decoction and Punarnava Mandoor in the management of kaphaj Pandu (Iron Deficiency Anaemia). Total no. of patient is 50, 25 in each group. In group A Punarnava Mandoor is given in dose of 2 tablets (250mg each) twice a day after 1 hour of meal with lukewarm water for 45 days. In group B Dashmool Visva kwath is given in dose of 40 ml twice a day after 1 hour of meal with lukewarm water for 45 days.

Study design is single centered, open label, randomized, interventional type, comparative study.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-02-15
• Last Update Posted: 2024-09-26
• Study Completion: 2024-10-02

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Patients not suffering from any severe disease other than Iron deficiency Anaemia.
• Haemoglobin level -between 6-11 gm/dl.
• Patients who can take medicines orally.

Exclusion Criteria

• Patients suffering from any other systemic diseases like Renal disorders, Heart disease, Cancer, acquired immune deficiency syndrome etc.
• Age <18 years and more than 60 years 3.
• Haemoglobin level-below 6 gm/dl and more than 11 gm/dl.
• Pregnant women and lactating mothers.
• Patients already taking any medicine for Anaemia.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in Haemoglobin Level	Day0 | Day15 | Day30 | Day45 | Day60

Secondary Outcome Measures

Name	Time	Method
Improvement in Following Clinical Features:	1-Pandutaa (Pallor), 2-Swash (Dyspnoea), 3-Bhrama (Dizziness)

Trial Locations

Locations (1)

Ch Brham Prakash Ayurved Charak Sansthan; 🇮🇳 West, DELHI, India

Ch Brham Prakash Ayurved Charak Sansthan

🇮🇳West, DELHI, India

Bhawana Agarwal

Principal investigator

8209048971

bhawanaagarwal95@gmail.com